AG

Artal Group Portfolio holdings

AUM $930M
1-Year Return 3.57%
This Quarter Return
+1.26%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.39B
AUM Growth
-$331M
Cap. Flow
-$46.2M
Cap. Flow %
-1.05%
Top 10 Hldgs %
49.11%
Holding
164
New
19
Increased
18
Reduced
12
Closed
14

Top Buys

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38.8M
2
OTLY
Oatly Group
OTLY
$36.7M
3
TRML icon
Tourmaline Bio
TRML
$30.3M
4
VERV
Verve Therapeutics
VERV
$30.1M
5
LENZ
LENZ Therapeutics
LENZ
$21.5M

Top Sells

1
BNTX icon
BioNTech
BNTX
$98.3M
2
INTC icon
Intel
INTC
$51.2M
3
CCXI
ChemoCentryx, Inc.
CCXI
$38.4M
4
AVGO icon
Broadcom
AVGO
$34.8M
5
BEKE icon
KE Holdings
BEKE
$34.2M

Sector Composition

1 Healthcare 83.34%
2 Consumer Discretionary 12.19%
3 Consumer Staples 0.83%
4 Industrials 0.53%
5 Materials 0.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MEIP icon
126
MEI Pharma
MEIP
$139M
$2.85M 0.06%
50,000
+12,000
+32% +$684K
CGEM icon
127
Cullinan Oncology
CGEM
$413M
$2.58M 0.05%
100,000
– –
KDNY
128
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.55M 0.05%
180,500
– –
KA
129
DELISTED
Kineta, Inc. Common Stock
KA
$2.53M 0.05%
31,056
– –
LVTX icon
130
LAVA Therapeutics
LVTX
$41.3M
$2.18M 0.04%
200,000
– –
MOLN
131
Molecular Partners
MOLN
$134M
$2.05M 0.04%
+100,000
New +$2.05M
CHMA
132
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.8M 0.04%
380,000
– –
IRWD icon
133
Ironwood Pharmaceuticals
IRWD
$188M
$1.42M 0.03%
110,532
– –
RIGL icon
134
Rigel Pharmaceuticals
RIGL
$742M
$1.39M 0.03%
32,110
– –
CEREW
135
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$1.15M 0.02%
79,600
– –
SURF
136
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$746K 0.02%
100,000
– –
LU icon
137
Lufax Holding
LU
$2.61B
$565K 0.01%
+12,500
New +$565K
CDTX icon
138
Cidara Therapeutics
CDTX
$1.6B
$454K 0.01%
11,234
– –
AA icon
139
Alcoa
AA
$8.24B
– –
0
– –
AVGO icon
140
Broadcom
AVGO
$1.58T
– –
-750,000
Closed -$34.8M
BAC icon
141
Bank of America
BAC
$369B
– –
0
– –
BEKE icon
142
KE Holdings
BEKE
$22.4B
– –
-600,000
Closed -$34.2M
BMRN icon
143
BioMarin Pharmaceuticals
BMRN
$11.1B
– –
0
– –
BMY icon
144
Bristol-Myers Squibb
BMY
$96B
– –
0
– –
BNTX icon
145
BioNTech
BNTX
$27B
– –
-900,000
Closed -$98.3M
C icon
146
Citigroup
C
$176B
– –
0
– –
CPNG icon
147
Coupang
CPNG
$52.7B
– –
-400,000
Closed -$19.7M
F icon
148
Ford
F
$46.7B
– –
0
– –
FCX icon
149
Freeport-McMoran
FCX
$66.5B
– –
0
– –
GDS icon
150
GDS Holdings
GDS
$6.35B
– –
-100,000
Closed -$8.11M
3 4 5
6
7